Oppenheimer increased its price target for Trevi Therapeutics Inc. (NASDAQ:TRVI) to $23 from $20, while maintaining an ...

Kymera Therapeutics Inc. (NASDAQ:KYMR) announced positive first-in-human results from its Phase 1 healthy volunteer clinical ...

AVEO Oncology, an LG Chem company ("AVEO"), a biopharmaceutical company committed to providing differentiated solutions to ...

Sionna Therapeutics is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment ...

Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, ...

The full invitation to the AGM 2025 may be found in the General Meetings section of the Company's website here.

Bristol-Myers Squibb Company (NYSE:BMY), which focuses on innovative cancer and immunology treatments, is a leader in the ...

Ascentage Pharma (NASDAQ: AAPG; HKEX: 6855), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that it has released the latest data from a Phase ...

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according ...

Scientific breakthroughs, operational innovation, and cultural shifts are driving tomorrow’s medicines.

Sanofi S.A. (Paris, France) and Blueprint Medicines Corp. (Blueprint), a U.S.-based, publicly traded biopharmaceutical company specializing in systemic ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.